Latest filing published 17 Sept 2026 for CRESCENT BIOPHARMA, INC., €135k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Joshua T Brumm in Crescent Biopharma, Inc. Between 16 September 2026 and 17 September 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 September 2026 came the latest disclosure, a transaction for €135k in Crescent Biopharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations